Hauser Announces Exclusive Distribution Agreement

BOULDER, Colo., Oct. 30, 2001 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) today announced that it signed an agreement to be the exclusive North American distributor of Clover Corporation's full line of DHA-rich tuna oil products. Clover Corporation (CLV.AX) is an Australian-based food technology company.

DHA (docosahexaenoic acid) is a nutritionally important Omega-3 fatty acid that helps build and maintain healthy cells in the brain. Studies have also shown DHA to promote healthy cells in other vital organs such as the heart and eyes.

Dieter Luelsdorf, vice president of Hauser's Functional Food Ingredients Group, said, "This agreement allows us to provide our customers high quality, versatile DHA-products that have a broad range of dietary supplement and functional food applications. The FDA's decision to allow DHA in infant formula will help raise awareness of this important nutrient."

Hauser, a Customer Connected(SM) company headquartered in Boulder, Colorado, is a leading supplier of herbal extracts and nutritional supplements. The company also provides interdisciplinary laboratory testing services, chemical engineering services, and contract research and development. The company's products and services are principally marketed to the pharmaceutical, dietary supplement and food ingredient businesses. Hauser's business units include: Botanicals International Extracts, Hauser Laboratories, Shuster Laboratories, and ZetaPharm.

Certain oral and written statements of management of the Companies included in this Press Release and elsewhere may contain forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. These statements include the plans and objectives of management for future operations. The forward-looking statements included herein and elsewhere are based on current expectations that involve judgments which are difficult or impossible to predict accurately and many of which are beyond the control of the Companies. Although the Companies believe that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements, the inclusion of such information should not be regarded as a representation by the Companies or any other person that the objectives and plans of the Companies will be achieved.


Contact Data